4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-029607
Chief Business Officer sold 2,434 shares at $25.85 ($62,919)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
McNeill Jonathan · Chief Business Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-03-07 | Sale : show line 1 in the form 10b5-1 | −2,434 | $25.85 | $62,919 | 141,184 | D |
| Open-market sales · 2,434 sh · avg $25.85 · $62,919 | ||||||
Loading xslF345X05/ownership.xml…